FATE earnings call for the period ending March 31, 2019.
News & Analysis: Fate Therapeutics
FATE earnings call for the period ending December 31, 2018.
These small biotech stocks are red-hot. But can they keep the momentum going?
Can the momentum continue for these hot biotech stocks?
Make that two consecutive days of riding the momentum from the Juno Therapeutics acquisition.